<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Enzyme Inhib Med Chem</span><span class="iso-abbrev" title="iso-abbrev">J Enzyme Inhib Med Chem</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Enzyme Inhibition and Medicinal Chemistry</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1475-6366</span><span class="issn-epub" tagx="issn" title="issn-epub">1475-6374</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/6968525">6968525</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/31899979">31899979</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/14756366.2019.1705292">10.1080/14756366.2019.1705292</a></span><span class="publisher-id" title="publisher-id">1705292</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span>: <span class="subject" title="subject">Research Paper</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent</div> <div class="alt-title" title="alt-title">
F. Pagniez et al.</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-1759-5106</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pagniez</span><span class="given-names" tagx="given-names" title="given-names">Fabrice</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-2280-7545</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lebouvier</span><span class="given-names" tagx="given-names" title="given-names">Nicolas</span></span><a href="#AF0002">b</a><a href="#AF0003">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Na</span><span class="given-names" tagx="given-names" title="given-names">Young Min</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-8159-0959</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ourliac-Garnier</span><span class="given-names" tagx="given-names" title="given-names">Isabelle</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Picot</span><span class="given-names" tagx="given-names" title="given-names">Carine</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-1398-075X</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Borgne</span><span class="given-names" tagx="given-names" title="given-names">Marc</span></span><a href="#AF0002">b</a><a href="#AF0004">d</a><a href="#AN0002" /></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-5059-6402</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Pape</span><span class="given-names" tagx="given-names" title="given-names">Patrice</span></span><a href="#AF0001">a</a><a href="#AN0001" /></span><span class="citation_author_institution" id="AF0001">[a], <span class="institution" title="institution">DÃ©partement de Parasitologie et Mycologie MÃ©dicale, UniversitÃ© de Nantes, Nantes Atlantique UniversitÃ©s, EA1155 - IICiMed, Institut de Recherche en SantÃ© 2</span><span class="city" tagx="city" title="city">Nantes</span><span class="country" tagx="country" title="country">France</span></span><span class="citation_author_institution" id="AF0002">[b], <span class="institution" title="institution">DÃ©partement de Chimie ThÃ©rapeutique, UniversitÃ© de Nantes, Nantes Atlantique UniversitÃ©s, EA1155 - IICiMed, Institut de Recherche en SantÃ© 2</span><span class="city" tagx="city" title="city">Nantes</span><span class="country" tagx="country" title="country">France</span></span><span class="citation_author_institution" id="AF0003">[c], <span class="institution" title="institution">Institut des Sciences Exactes et AppliquÃ©es (ISEA) - EA 7484, UniversitÃ© de la Nouvelle-CalÃ©donie</span><span class="city" tagx="city" title="city">Noumea Cedex</span><span class="country" tagx="country" title="country">New Caledonia</span></span><span class="citation_author_institution" id="AF0004">[d], <span class="institution" title="institution">EA 4446 Bioactive Molecules and Medicinal Chemistry, FacultÃ© de Pharmacie - ISPB, SFR SantÃ© Lyon-Est CNRS UMS3453 - INSERM US7, UniversitÃ© de Lyon, UniversitÃ© Claude Bernard Lyon 1</span><span class="city" tagx="city" title="city">Lyon</span><span class="country" tagx="country" title="country">France</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp">
CONTACT Patrice Le Pape <span class="email" tagx="email" title="email">patrice.le-pape@univ-nantes.fr</span><span class="institution" title="institution">Department of Parasitology and Medical Mycology, IICiMed UPRES EA 1155, Institut de Recherche en SantÃ© 2, UniversitÃ© de Nantes</span>, <span class="addr-line" title="addr-line">22 Boulevard BÃ©noni Goullin</span>, <span class="postal-code" tagx="postal-code" title="postal-code">44200</span><span class="city" tagx="city" title="city">Nantes</span>, <span class="country" tagx="country" title="country">France</span>; </div> <div class="corresp" title="corresp">
Marc Le Borgne <span class="email" tagx="email" title="email">marc.le-borgne@univ-lyon1.fr</span><span class="institution" title="institution"> EA 4446 Bioactive Molecules and Medicinal Chemistry, FacultÃ© de Pharmacie - ISPB, UniversitÃ© Claude Bernard Lyon 1</span>, <span class="addr-line" title="addr-line">8 avenue Rockefeller, Lyon cedex 8</span>, <span class="postal-code" tagx="postal-code" title="postal-code">F-69373</span>, <span class="country" tagx="country" title="country">France</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2020-1-1</span></span><span class="pub-date-" title="pub-date-">: <span>2020</span></span><span class="volume" tagx="volume" title="volume">35</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">398</span><span class="lpage" tagx="lpage" title="lpage">403</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">The Author(s)</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="IENZ_35_1705292.pdf" title="self-uri">IENZ_35_1705292.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>(2-(2,4-Dichlorophenyl)-3-(1<i>H</i>-indol-1-yl)-1-(1,2,4-1<i>H</i>-triazol-1-yl)propan-2-ol (<b>8â€‰g</b>), a new 1,2,4-triazole-indole hybrid molecule, showed a broad-spectrum activity against <i>Candida,</i> particularly against low fluconazole-susceptible species. Its activity was higher than fluconazole and similar to voriconazole on <i>C. glabrata</i> (MIC<sub>90</sub> = 0.25, 64 and 1â€‰Âµg/mL, respectively), <i>C. krusei</i> (MIC<sub>90</sub> = 0.125, 64 and 0.125â€‰Âµg/mL, respectively) and <i>C. albicans</i> (MIC<sub>90</sub> = 0.5, 8 and 0.25â€‰Âµg/mL, respectively). The action mechanisms of <b>8â€‰g</b> were also identified as inhibition of ergosterol biosynthesis and phospholipase A2-like activity. At concentration as low as 4 ng/mL, 8g inhibited ergosterol production by 82% and induced production of 14a-methyl sterols, that is comparable to the results obtained with fluconazole at higher concentration. <b>8â€‰g</b> demonstrated moderate inhibitory effect on phospholipase A2-like activity being a putative virulence factor. Due to a low MRC5 cytotoxicity, this compound presents a high therapeutic index. These results pointed out that <b>8â€‰g</b> is a new lead antifungal candidate with potent ergosterol biosynthesis inhibition.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Triazole-indole hybrid</div> <div class="kwd" title="kwd"><i>Candida</i> species</div> <div class="kwd" title="kwd">
ergosterol production</div> <div class="kwd" title="kwd">
phospholipase A2-like activity</div> <div class="kwd" title="kwd"><i>inÂ vivo</i> evaluation</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
Introduction</div> <p>During the last decades, the frequency of fungal infections has increased because of human immunodeficiency virus infection and more intensive and cytotoxic chemotherapies<a href="#CIT0001"><sup>1</sup></a>. In AIDS, oncology and transplantation patients, <i>Candida</i> still one of the major opportunistic pathogens<a href="#CIT0002"><sup>2</sup></a><sup>,</sup><a href="#CIT0003"><sup>3</sup></a>. Options for treatment of severe fungal infections are primarily amphotericin B, azole compounds and echinocandins<a href="#CIT0004"><sup>4</sup></a>. Although amphotericin B and its lipid formulations decrease the morbidity and mortality, they must be given intravenously, are extremely expensive and still carry significant infusion-related toxicity. Echinocandins, one of the first-line therapy in neutropenic patients reveal a high antifungal activity against <i>Candida spp</i><a href="#CIT0005"><sup>5</sup></a>. However, resistance emergence has been described for <i>C. albicans</i> and the haploÃ¯d yeast <i>C. glabrata</i><a href="#CIT0006"><sup>6</sup></a>. Furthermore, elevated MICs have been reported in the case of <i>C. parapsilosis</i>.</p> <p>Fluconazole and fourth generation of azoles (e.g. voriconazole, posaconazole and isavuconazole) remain the most frequently used drugs for treatment of <i>Candida</i> infections<a href="#CIT0007"><sup>7</sup></a>. However, azole resistance of <i>C. albicans</i> and non-<i>albicans Candida,</i> such as <i>C. krusei and C. glabrata,</i> naturally resistant or low-sensitive to fluconazole, have been reported<a href="#CIT0008"><sup>8</sup></a><sup>,</sup><a href="#CIT0009"><sup>9</sup></a>. Even if new targets have been successfully explored as well as cell wall formation<a href="#CIT0010"><sup>10</sup></a>, ergosterol synthesis inhibition has been the major objective of new antifungal drugs being ravuconazole and isavucoanzole the most recent clinically available drugs. Most of new antifungal targets presented in the literature exhibited little potential to develop target-based inhibitors being pharmacomodulation of non-toxic azole a good alternative<a href="#CIT0011"><sup>11</sup></a>.</p> <p>Indolylazole derivatives are a new class of azole antifungal drugs<a href="#CIT0012"><sup>12</sup></a> which have demonstrated <i>inÂ vitro</i> activities against <i>Aspergillus</i><a href="#CIT0013"><sup>13</sup></a> and protozoa such as <i>Leishmania</i><a href="#CIT0014"><sup>14</sup></a><sup>,</sup><a href="#CIT0015"><sup>15</sup></a>. More recently, structural modifications were done to enable a specific and broad activity against <i>Candida</i> spp., including fluconazole low-susceptible species as <i>C. krusei</i> and <i>C. glabrata</i>.</p> <p><i>Candida</i> spp. are known to produce several types of phospholipases such as phospholipase B and phospholipase A which were detected in culture supernatant<a href="#CIT0016"><sup>16</sup></a><sup>,</sup><a href="#CIT0017"><sup>17</sup></a>. The virulence of <i>Candida</i> strains in <i>G. mellonella</i> is related to the quantity of phospholipases production<a href="#CIT0018"><sup>18</sup></a> and strains isolated from symptomatic women with vulvovaginal candidiasis exhibit high level of phospholipase activity<a href="#CIT0019"><sup>19</sup></a>. Phospholipase B has been described as a pathogenic factor that contributes to host membrane degradation and penetration of <i>C. albicans</i> pseudohyphae<a href="#CIT0020"><sup>20</sup></a>. Intracellular phospholipases, identified as phospholipases A, have been localised at the site of bud formation<a href="#CIT0021"><sup>21</sup></a>. Triglyceride lipases with phospholipase A2-like activity (patatin-like homologs) have been described in <i>Saccharomyces</i> and <i>Candida</i><a href="#CIT0022"><sup>22</sup></a>. Already known function of this phospholipase is hydrolysis of fatty acids for membrane formation and sporulation. Since indole derivatives have been reported as inhibitors of phospholipase A<sub>2</sub> activity<a href="#CIT0010"><sup>10</sup></a><sup>,</sup><a href="#CIT0023"><sup>23</sup></a> our 2-dichlorophenyl-3-triazolyl-1-indolyl-propan-2-ol derivative (<b>8â€‰g</b>) could be of interest to inhibit this enzyme activity.</p> <p>In this work, we present the potent anti-<i>Candida</i> activity of <b>8â€‰g</b>, an indole-triazole derivative, against <i>C. albicans</i> and non-<i>albicans</i> clinical isolates and its mechanism of action as inhibitor of ergosterol biosynthesis and phospholipase A2-like activity.</p> </div> <div class="materials" title="materials"> <div class="title" tagx="title" title="title">
Materials and methods</div> <div class="strains" title="sec"> <div class="title" tagx="title" title="title">
Strains</div> <p>Control strains used for <i>inÂ vitro</i> evaluation were the CLSI reference strains, including <i>Candida albicans</i> ATCC 2091, <i>C. glabrata</i> CBS 138, <i>C. krusei</i> ATCC 6258, <i>C. parapsilosis</i> ATCC 22019 and <i>C. parapsilosis</i> ATCC 90018. Additionally, numerous clinical isolates from the collection of EA1155 IICiMed were used: <i>C. albicans</i> (<i>n</i>â€‰=â€‰26), <i>C. glabrata</i> (<i>n</i>â€‰=â€‰12), <i>C. krusei</i> (<i>n</i>â€‰=â€‰14), <i>C. parapsilosis</i> (<i>n</i>â€‰=â€‰18) and <i>C. tropicalis</i> (<i>n</i>â€‰=â€‰6). The selected species are representative of the European epidemiology and therefore correspond to the five most prevalent species in the clinic settings<a href="#CIT0024"><sup>24</sup></a>. Strains were maintained and subcultured 24â€‰h before used on Sabouraudâ€™s agar slants.</p> </div> <div class="chemicals" title="sec"> <div class="title" tagx="title" title="title">
Chemicals</div> <p>Indole-triazole derivative compound <b>8â€‰g</b>, (2â€"(2,4-dichlorophenyl)-3-(1<i>H</i>-indol-1-yl)-1â€"(1,2,4-1<i>H</i>-triazol-1-yl)-propan-2-ol (<a href="#F0001">Figure 1</a>), was synthesised in the Department of Medicinal Chemistry, EA1155 IICiMed. The chemical synthesis route of <b>8â€‰g</b> and its derivatives (not described in this article) was achieved with regard to the synthesis of new analogues of fluconazole.<a href="#CIT0025"><sup>25</sup></a><b>8â€‰g</b> was dissolved in DMSO to prepare a stock solution at 10â€‰mg/mL. This stock solution was diluted in RPMI 1640 for <i>inÂ vitro</i> experiment. For <i>inÂ vivo</i> studies, to avoid injecting DMSO, compound <b>8â€‰g</b> was prepared in 0.5% Tween 20-sterile saline solution. Fluconazole and voriconazole (Pfizer) were obtained from Mycobiotics. Stock solutions were prepared in water and DMSO, respectively, at a concentration of 10â€‰mg/mL.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>Chemical structure of <b>8â€‰g</b>.</p>   </div> </div> <div class="antifungalsusceptibilitytesting" title="sec"> <div class="title" tagx="title" title="title">
Antifungal susceptibility testing</div> <p>MICs for <i>Candida</i> strains were determined by the broth microdilution method with RPMI 1640 medium (Sigma Aldrich, Saint Quentin fallavier, France) according to the procedures of the Clinical and Laboratory Standard Institute described in document M27-A2<a href="#CIT0026"><sup>26</sup></a>. Yeasts were grown on Sabouraud dextrose agar (Difco Laboratories) at 35â€‰Â°C for 24â€‰h. The wells were inoculated with 100â€‰ÂµL of the culture suspension diluted to a final inoculum of 5 x 10<sup>2</sup> to 2.5 x 10<sup>3</sup> cells/mL. Fungal growth was observed 48â€‰h after incubation at 35â€‰Â°C. The MICs of the azoles were the lowest drug concentrations to give a 50% decrease in turbidity from that of the control fungal growth. MIC<sub>90</sub> was the concentration of a drug required at which 90% of the clinical isolates tested were inhibited.</p> </div> <div class="mrc5toxicityassay" title="sec"> <div class="title" tagx="title" title="title">
MRC5 toxicity assay</div> <p>Cytotoxicity of compounds was studied with human fibroblast (MRC5). Cells were grown in RPMI 1640 medium (Sigma-aldrich) supplemented with 10% foetal bovin serum (Sigma-aldrich). Drugs were tested at three concentrations (100, 10 and 1â€‰ÂµM) in triplicate. After a 96â€‰h-incubation time cytotoxicity was measured on the Fluorolite 1000 (Dynatech, France) after a 4-h incubation time with Uptiblue<sup>Â®</sup> (Interchim, MontluÃ§on, France). Inhibitory concentration 50 is a mean of triplicate values. A toxicity index was determined as follow: IC<sub>50</sub> against MRC5/Geometric mean of the MICs against <i>Candida spp</i>.</p> </div> <div class="phospholipasea2activity" title="sec"> <div class="title" tagx="title" title="title">
Phospholipase A<sub>2</sub> activity</div> <p>Phospholipase A<sub>2</sub>-like activity (PLA<sub>2</sub>) was quantified in cells and culture supernatant of <i>C. albicans</i> CA98001 clinical isolate incubated for 1â€‰h at 37â€‰Â°C with the specific modified phospholipase A<sub>2</sub> substrate, 1-octadecanoyl-2â€"(1-<sup>14</sup>C)-eicosatetraenoyl-glycerol-3-phosphocholine. Lipids were extracted with chloroform/methanol mixture. Aliquots of chloroformic phases were placed in scintillation flasks for measures of total lipid radioactivity. The chromatography solvent phase was toluene/dioxane/acetic acid/formic acid 85/15/0.2/0.2 (v/v). Lipid classes were visualised with iodine vapours on an analytical thin-layer chromatography. Each spot was cut and the lipids were solubilised in scintillation liquid. Then, radioactivity was measured in a LKB 1909 scintillation spectrophotometer<a href="#CIT0008"><sup>8</sup></a>. PLA<sub>2</sub> activity was expressed as the ratio of radioactive fatty acids versus total radioactivity of sample.</p> <p>Compound <b>8â€‰g</b> was introduced 30â€‰min before the radioactive substrate at a concentration of 10â€‰ÂµM. A known inhibitor of PLA2, the 4-bromophenacyl bromide (BpB) was used as reference at a concentration of 10â€‰ÂµM.</p> </div> <div class="sterolextraction" title="sec"> <div class="title" tagx="title" title="title">
Sterol extraction</div> <p>To study sterol synthesis, <i>Candida albicans</i> CAAL93, <i>C. krusei</i> CAKR7 and <i>C. glabrata</i> CAGL2 blastopores were incubated in 50â€‰ml Sabouraud broth medium (Sigma) during 18â€‰h at 35â€‰Â°C with stirring. Cells were collected by centrifugation at 1500â€‰g. Pellet was suspended in 3â€‰ml of fresh ethanolic potassium hydroxide solution (25â€‰g of KOH, 36â€‰ml of distilled water and brought to 100â€‰ml with 100% ethanol). Saponification was performed at 80â€‰Â°C for 60â€‰min. Sterols were extracted by addition of 3â€‰ml of hexane and the organic phase was then washed by adding 1â€‰ml of sterile water. Final organic phase was transferred to a new collection tube after 5â€‰min centrifugation step at 2000â€‰rpm.</p> </div> <div class="sterolanalysis" title="sec"> <div class="title" tagx="title" title="title">
Sterol analysis</div> <p>Sterols as TMS derivatives were analysed by GC-MS using an Agilent 6890â€‰N GC system, with a HP-5MS column (30â€‰m x 0.25â€‰mm ID, 0.25â€‰Âµm film thickness, Agilent Technologies) coupled with a quadrupole mass detector (Agilent 5973i â€" E.I. 70â€‰eV). Two microliters of sample were injected in splitless mode at 250â€‰Â°C. The carrier gas was helium at a flow rate of 1.2â€‰mL/min. The oven was set at 150â€‰Â°C for 0.5â€‰min and then raised to 280â€‰Â°C at 40â€‰Â°C/min and from 280â€‰Â°C to 300â€‰Â°C at 2â€‰Â°C/min. Sterols were identified via their electron ionisation fragmentation pattern, compared to published data. Results are expressed as percent area of total sterols.</p> </div> <div class="invivoactivity" title="sec"> <div class="title" tagx="title" title="title"><i>In vivo</i> activity</div> <div class="animaluseandcare" title="sec"> <div class="title" tagx="title" title="title">
Animal use and care</div> <p>Swiss female mice (Janvier Labs, Le Genest-Saint-Isle, France) with a body weight of âˆ¼25â€‰g were obtained and allowed to acclimate for a minimum of 5â€‰days prior to use. Environmental controls for the animal room were set to maintain a temperature of 16 to 22â€‰Â°C, a relative humidity of 30 to 70%, and a 12:12 hourly light-dark cycle.</p> </div> <div class="systemicc.albicansinfectionmodel" title="sec"> <div class="title" tagx="title" title="title">
Systemic C. albicans infection model</div> <p>Mice (8 per groups) were immunodepressed by subcutaneous injection of 30â€‰mg/kg prednisolone one day before challenge. On day 0, mice were infected intravenously with <i>C. albicans</i> (CAAL93) blastoconidia (5.10<sup>5</sup> in 100â€‰ÂµL of NaCl 0.9%). One hour after infection, mice were treated intraperitoneally for five consecutive days with 100â€‰ÂµL 0.5% Tween 20-sterile saline solution (control), twice daily with 30â€‰mg/kg or three times a day with 20â€‰mg/kg body weight of compound <b>8â€‰g</b>. Fluconazole (Sigma, St Quentin Fallavier, France) was administered <i>per os</i> three times a day at 5â€‰mg/kg. Mice were monitored for 14â€‰days post inoculation. For reduction of animal distress, the body weights of the mice were recorded daily, and when they lost 20% of their initial weight, mice were euthanized. On day 14, all surviving mice were euthanized.</p> </div> </div> <div class="statisticalanalysis" title="sec"> <div class="title" tagx="title" title="title">
Statistical analysis</div> <p>The results were statistically analysed using the software Graphpad PRISM 7.0. The log-rank (Mantel-Cox) test was performed for survival analysis. A <i>p</i> values &amp;lt; 0.05 was considered significant.</p> </div> </div> <div class="results" title="results"> <div class="title" tagx="title" title="title">
Results</div> <p>Antifungal activities (MICs) of <b>8â€‰g</b> and reference compounds (fluconazole and voriconazole) against our set of clinical <i>Candida</i> strains are summarised in <a href="#t0001">Table 1</a>. Against CLSI quality control strains, MICs of <b>8â€‰g</b> were 0.125, 0.016 and 0.032â€‰Âµg/mL for <i>C. krusei</i> ATCC6258, <i>C. parapsilosis</i> ATCC22019 and <i>C. parapsilosis</i> ATCC90018, respectively. This compound displayed high significant <i>inÂ vitro</i> activity against the most clinically important species tested especially against low-susceptible or resistant <i>C. glabrata</i> and <i>C. krusei</i>. Indeed, <b>8â€‰g</b> was always more potent than fluconazole and at least as potent as voriconazole. MIC<sub>90</sub>s against <i>C. glabrata</i> and <i>C. krusei</i> were as low as 0.25 and 0.125â€‰Âµg/mL, respectively, while MIC<sub>90</sub>s of fluconazole were 64 and &amp;gt; 64â€‰Âµg/mL, respectively. MIC<sub>90</sub>s of voriconazole were 4 and 4â€‰Âµg/mL, respectively. MIC<sub>90</sub>s against completely tested strains were 0.5, 64 and 1â€‰Âµg/mL for <b>8â€‰g</b>, fluconazole and voriconazole, respectively.</p> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>Antifungal susceptibilities of <i>Candida</i> spp. to <b>8â€‰g</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th rowspan="2" align="left">Species<br /><br />(no. of isolates)</th> <th rowspan="2" align="center">Antifungal agent</th> <th colspan="3" align="center">MIC (Âµg/mL) <hr /> </th> </tr> <tr> <th align="center">Range</th> <th align="center">Geometric mean</th> <th align="center">MIC<sub>90</sub></th> </tr> </thead> <tbody valign="top"> <tr> <td rowspan="3"><i>C. albicans</i> (27)</td> <td align="left"><b>8g</b></td> <td align="char" char=".">&amp;lt; 0.016â€"4</td> <td align="char" char=".">0.038</td> <td align="char" char=".">0.5</td> </tr> <tr> <td align="left">fluconazole</td> <td align="char" char=".">&amp;lt; 0.125 â€" &amp;gt; 64</td> <td align="char" char=".">0.696</td> <td align="char" char=".">8</td> </tr> <tr> <td align="left">voriconazole</td> <td align="char" char=".">&amp;lt; 0.016 â€" &amp;gt; 8</td> <td align="char" char=".">0.042</td> <td align="char" char=".">0.25</td> </tr> <tr> <td rowspan="3"><i>C. glabrata</i> (13)</td> <td align="left"><b>8g</b></td> <td align="char" char=".">&amp;lt; 0.06â€"0.5</td> <td align="char" char=".">0.06</td> <td align="char" char=".">0.25</td> </tr> <tr> <td align="left">fluconazole</td> <td align="char" char=".">0.016 â€" &amp;gt; 64</td> <td align="char" char=".">4</td> <td align="char" char=".">64</td> </tr> <tr> <td align="left">voriconazole</td> <td align="char" char=".">0.016â€"4</td> <td align="char" char=".">0.25</td> <td align="char" char=".">1</td> </tr> <tr> <td rowspan="3"><i>C. krusei</i> (15)</td> <td align="left"><b>8g</b></td> <td align="char" char=".">0.016â€"1</td> <td align="char" char=".">0.109</td> <td align="char" char=".">0.125</td> </tr> <tr> <td align="left">fluconazole</td> <td align="center">8 â€" &amp;gt; 64</td> <td align="char" char=".">23</td> <td align="char" char=".">64</td> </tr> <tr> <td align="left">voriconazole</td> <td align="char" char=".">0.016â€"4</td> <td align="char" char=".">0.158</td> <td align="char" char=".">0.125</td> </tr> <tr> <td rowspan="3"><i>C. parapsilosis</i> (20)</td> <td align="left"><b>8g</b></td> <td align="char" char=".">&amp;lt; 0.016â€"0.125</td> <td align="char" char=".">0.029</td> <td align="char" char=".">0.0625</td> </tr> <tr> <td align="left">fluconazole</td> <td align="char" char=".">&amp;lt; 0.125 â€" &amp;gt; 64</td> <td align="char" char=".">0.661</td> <td align="char" char=".">8</td> </tr> <tr> <td align="left">voriconazole</td> <td align="char" char=".">&amp;lt; 0.016â€"0.25</td> <td align="char" char=".">0.017</td> <td align="char" char=".">0.125</td> </tr> <tr> <td rowspan="3"><i>C. tropicalis</i> (6)</td> <td align="left"><b>8g</b></td> <td align="char" char=".">&amp;lt; 0.016â€"1</td> <td align="char" char=".">Â </td> <td align="char" char=".">Â </td> </tr> <tr> <td align="left">fluconazole</td> <td align="char" char=".">&amp;lt; 0.125â€"64</td> <td align="char" char=".">Â </td> <td align="char" char=".">Â </td> </tr> <tr> <td align="left">voriconazole</td> <td align="char" char=".">&amp;lt; 0.016â€"0.5</td> <td align="char" char=".">Â </td> <td align="char" char=".">Â </td> </tr> <tr> <td rowspan="3"><i>Candida</i> spp. (81)</td> <td align="left"><b>8g</b></td> <td align="char" char=".">&amp;lt; 0.016â€"4</td> <td align="char" char=".">0.048</td> <td align="char" char=".">0.5</td> </tr> <tr> <td align="left">fluconazole</td> <td align="char" char=".">&amp;lt; 0.125 â€" &amp;gt; 64</td> <td align="char" char=".">2</td> <td align="char" char=".">64</td> </tr> <tr> <td align="left">voriconazole</td> <td align="char" char=".">&amp;lt; 0.016 â€" &amp;gt; 8</td> <td align="char" char=".">0.059</td> <td align="char" char=".">1</td> </tr> </tbody> </table> </div> <p>Cytotoxicity evaluated on human fibroblast (MRC5) showed an IC<sub>50</sub> of 35â€‰ÂµM for <b>8â€‰g</b> that is lower than for fluconazole or voriconazole (IC<sub>50 </sub>&amp;gt;100â€‰ÂµM). Nevertheless, its cytoxicity occurred at concentration 280-time higher than geometric mean MIC against <i>Candida</i> (while fluconazole and voriconazole toxicity index were &amp;gt; 15 and &amp;gt; 590, respectively).</p> <p>Compound <b>8â€‰g</b> was evaluated <i>inÂ vivo</i> in a mouse model of systemic candidiasis. Survival of mice was significantly (<i>p</i>â€‰<div class="â€‰0.01)_UNKNOWN">
8â€‰g groups than in the control group (<a href="#F0002">Figure 2</a>). In the fluconazole group (3Â xÂ 5â€‰mg/kg) and in the <b>8â€‰g</b> group (3Â xÂ 20â€‰mg/kg), all mice survived. Moreover, a treatment three times a day (3Â xÂ 20â€‰mg/kg) was significantly (<i>p</i>â€‰<div class="â€‰0.05)_UNKNOWN"> </div></div></p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>Survival curve of mice after treatment with fluconazole (3 x 5â€‰mg/kg <i>per os</i>, â–¡) or <b>8â€‰g</b> (2Â xÂ 30â€‰mg/kg ip, Î"; 3Â xÂ 20â€‰mg/kg ip, â–²). Control group (â—�). **<i>p</i>â€‰<div class="â€‰0.01;_UNKNOWN">
pâ€‰&amp;lt;0â€‰.001.</div></p>   </div> <p>A PLA2-like activity was clearly characterised in <i>C. albicans</i> CA98001, including cytosolic PLA2 (cPLA2) and secreted PLA2 activities. Indeed, using intact <i>Candida</i> cells, 53% and 34% of PLA2 activity was inhibited by 10â€‰ÂµM BpB and <b>8â€‰g</b>, respectively (<a href="#t0002">Table 2</a>). In the case of <b>8â€‰g</b>, the impact on the production of arachidonic acid is marked (0.12 for <b>8â€‰g</b><i>versus</i> 0.22 for the control).</p> <div class="table-wrap_UNKNOWN" id="t0002" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2.</span> <p>Hydrolysis inhibition of the 1-octadecanoyl 2â€"(1-<sup>14â€‰</sup>C) eicosatetraenoyl glycerol-3-phosphocholine after treatment with bromophenacyl bromide (BpB) and <b>8â€‰g</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Â </th> <th colspan="3" align="center">Inhibitors (Meanâ€‰Â±â€‰SEM) <hr /> </th> </tr> <tr> <th align="left">Â </th> <th align="center">Control</th> <th align="center">BpB</th> <th align="center"><b>8g</b></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left">phospholipids</td> <td align="char" char="Â±">1.18â€‰Â±â€‰0.18</td> <td align="char" char="Â±">1.32â€‰Â±â€‰0.01</td> <td align="char" char="Â±">1.10â€‰Â±â€‰0.01</td> </tr> <tr> <td align="left">mono- &amp;amp; diglycerides</td> <td align="char" char="Â±">0.12â€‰Â±â€‰0.04</td> <td align="char" char="Â±">0.12â€‰Â±â€‰0.01</td> <td align="char" char="Â±">0.14â€‰Â±â€‰0.02</td> </tr> <tr> <td align="left">arachidonic acid</td> <td align="char" char="Â±">0.22â€‰Â±â€‰0.04</td> <td align="char" char="Â±">0.11â€‰Â±â€‰0.01</td> <td align="char" char="Â±">0.12â€‰Â±â€‰0.02</td> </tr> <tr> <td align="left">triglycerides &amp;amp; others</td> <td align="char" char="Â±">0.26â€‰Â±â€‰0.13</td> <td align="char" char="Â±">0.31â€‰Â±â€‰0.16</td> <td align="char" char="Â±">0.12â€‰Â±â€‰0.01</td> </tr> <tr> <td align="left">total lipids</td> <td align="char" char="Â±">1.79â€‰Â±â€‰0.05</td> <td align="char" char="Â±">1.86â€‰Â±â€‰0.15</td> <td align="char" char="Â±">1.48â€‰Â±â€‰0.04</td> </tr> <tr> <td align="left">PLA2 like activity (%)</td> <td align="char" char="Â±">12.5â€‰Â±â€‰2.6</td> <td align="char" char="Â±">5.9â€‰Â±â€‰0.79</td> <td align="char" char="Â±">8.2â€‰Â±â€‰1.06</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Radioactivity of the lipid classes is expressed in nmol.L<sup>âˆ’1</sup>.min<sup>âˆ’1</sup>/10<sup>8</sup> cells. Phospholipase activity is expressed as the percentage of fatty acid released from the total radiolabelled phospholipids.</p> </div> </div> </div> <p>GC-MS analysis of sterol profile of three different clinical strains of <i>C. albicans</i> (CAAL93), C. <i>krusei</i> (CAKR7) and C. <i>glabrata</i> (CAGL2) showed ergosterol as the major sterol accounting for 69% to 83% of total cellular sterols. Small quantities of ergosterol intermediates such as zymosterol, ergosta-7,22-dienol, fecosterol and episterol were also detected to a lesser extent (between 2% and 5%). Ergosterol precursor in <i>Candida</i>, i.e. lanosterol, was also found in a small quantity (0.7% to 5.2%). These sterol profiles were in accordance with classical metabolism of ergosterol<a href="#CIT0027"><sup>27</sup></a>. Treatment with <b>8â€‰g</b> (4â€‰ng/mL) of C. <i>albicans</i> fluconazole-susceptible strain (CAAL93 â€" MIC = 0.125â€‰Âµg/mL) resulted in a significant reduction of ergosterol content (70%), an accumulation of lanosterol and the emerging of 14Î±-methyl sterols such as eburicol, 14Î±-methylfecosterol and 14Î±-methylepisterol. Same modifications in sterol profile were observed when CAAL93 was treated with fluconazole at a 1000-fold higher dose (4â€‰Âµg/mL) (<a href="#t0003">Table 3</a>).</p> <div class="table-wrap_UNKNOWN" id="t0003" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3.</span> <p>Sterol profile of <i>C. albicans</i> (CAAL93), <i>C. krusei</i> (CAKR7) and <i>C. glabrata</i> (CAGL2) untreated and treated with fluconazole (FLU: 4â€‰Âµg/mL) or <b>8â€‰g</b> (4â€‰ng/mL or 4â€‰Âµg/mL). â€": not detected.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Â </th> <th align="center">Â </th> <th colspan="3" align="center"><i>CAAL93</i><hr /> </th> <th colspan="3" align="center"><i>CAKR7</i><hr /> </th> <th colspan="3" align="center"><i>CAGL2</i><hr /> </th> </tr> <tr> <th align="left">Â </th> <th align="center">Â </th> <th rowspan="2" align="center">control</th> <th align="center"><b>8g</b></th> <th align="center">FLU</th> <th rowspan="2" align="center">control</th> <th align="center"><b>8g</b></th> <th align="center">FLU</th> <th rowspan="2" align="center">control</th> <th align="center"><b>8g</b></th> <th align="center">FLU</th> </tr> <tr> <th align="left">Â </th> <th align="center">R.T.</th> <th align="center">4â€‰ng/mL</th> <th align="center">4 Âµg/mL</th> <th align="center">4 Âµg/mL</th> <th align="center">4 Âµg/mL</th> <th align="center">4 Âµg/mL</th> <th align="center">4 Âµg/mL</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><i>zymosterol</i></td> <td align="char" char=".">9.34</td> <td align="char" char=".">4.8</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">2.4</td> <td align="center">â€"</td> <td align="char" char=".">Â </td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>24-ethyl-cholesta-5,7,22-trienol</i></td> <td align="char" char=".">9.49</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">8.5</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><b><i>ergosterol</i></b></td> <td align="char" char="."><b>9.55</b></td> <td align="char" char="."><b>69.4</b></td> <td align="char" char="."><b>21.6</b></td> <td align="char" char="."><b>â€"</b></td> <td align="char" char="."><b>83.1</b></td> <td align="char" char="."><b>60.1</b></td> <td align="char" char="."><b>84.3</b></td> <td align="char" char="."><b>78.4</b></td> <td align="char" char="."><b>41.6</b></td> <td align="char" char="."><b>79.9</b></td> </tr> <tr> <td align="left"><i>14Î±-methylepisterol</i></td> <td align="char" char=".">9.71</td> <td align="center">â€"</td> <td align="char" char=".">13.5</td> <td align="char" char=".">30.7</td> <td align="center">â€"</td> <td align="char" char=".">3.5</td> <td align="char" char=".">Â </td> <td align="center">â€"</td> <td align="char" char=".">2.6</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>ergosta-7,22-dienol</i></td> <td align="char" char=".">9.73</td> <td align="char" char=".">5.5</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>fecosterol</i></td> <td align="char" char=".">9.80</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">1.9</td> <td align="center">â€"</td> <td align="char" char=".">1.8</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>14Î±-methylfecosterol</i></td> <td align="char" char=".">9.97</td> <td align="center">â€"</td> <td align="char" char=".">10.0</td> <td align="char" char=".">10.8</td> <td align="center">â€"</td> <td align="char" char=".">4.9</td> <td align="char" char=".">Â </td> <td align="center">â€"</td> <td align="char" char=".">3.5</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>ergostadien-3Î²-ol (5,7 or 5,8)</i></td> <td align="char" char=".">10.05</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">1.1</td> <td align="center">â€"</td> <td align="char" char=".">1.1</td> <td align="char" char=".">3.7</td> <td align="char" char=".">2.2</td> <td align="char" char=".">7.6</td> </tr> <tr> <td align="left"><i>episterol</i></td> <td align="char" char=".">10.26</td> <td align="char" char=".">3.4</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">1.9</td> <td align="center">â€"</td> <td align="char" char=".">3.5</td> </tr> <tr> <td align="left"><b><i>14</i></b><i>Î±</i><b><i>-3,6-diol</i></b></td> <td align="char" char="."><b>10.41</b></td> <td align="char" char="."><b>â€"</b></td> <td align="char" char="."><b>â€"</b></td> <td align="char" char="."><b>â€"</b></td> <td align="char" char="."><b>â€"</b></td> <td align="char" char=".">Â </td> <td align="char" char=".">Â </td> <td align="char" char="."><b>â€"</b></td> <td align="char" char="."><b>23.4</b></td> <td align="char" char="."><b>â€"</b></td> </tr> <tr> <td align="left"><b><i>lanosterol</i></b></td> <td align="char" char="."><b>10.55</b></td> <td align="char" char="."><b>5.2</b></td> <td align="char" char="."><b>35.4</b></td> <td align="char" char="."><b>34.2</b></td> <td align="char" char="."><b>0.7</b></td> <td align="char" char="."><b>24.2</b></td> <td align="char" char="."><b>1.8</b></td> <td align="char" char="."><b>3.6</b></td> <td align="char" char="."><b>â€"</b></td> <td align="char" char="."><b>1.9</b></td> </tr> <tr> <td align="left"><i>obtusifoliol</i></td> <td align="char" char=".">10.60</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">23.8</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>4,4-dimethylcholesta-8,24-dienol</i></td> <td align="char" char=".">10.80</td> <td align="char" char=".">1.4</td> <td align="char" char=".">Â </td> <td align="char" char=".">Â </td> <td align="char" char=".">1.2</td> <td align="char" char=".">Â </td> <td align="char" char=".">1.1</td> <td align="char" char=".">2.7</td> <td align="char" char=".">Â </td> <td align="char" char=".">2.1</td> </tr> <tr> <td align="left"><i>eburicol</i></td> <td align="char" char=".">11.20</td> <td align="center">â€"</td> <td align="char" char=".">19.0</td> <td align="char" char=".">15.7</td> <td align="center">â€"</td> <td align="char" char=".">3.9</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="char" char=".">0.7</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><i>other sterols</i></td> <td align="char" char=".">Â </td> <td align="char" char=".">10.3</td> <td align="char" char=".">0.5</td> <td align="char" char=".">0</td> <td align="char" char=".">9.5</td> <td align="char" char=".">3.5</td> <td align="char" char=".">10.0</td> <td align="char" char=".">9.6</td> <td align="char" char=".">2.2</td> <td align="char" char=".">7.1</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>R.T.: retention time; Other sterols: sterols &amp;lt;1% or unidentified sterols. Bold: sterols of major interest (lanosterol = precursor, ergosterol = final product and 14a-3,6-diol = toxic final product)</p> </div> </div> </div> <p>Two fluconazole-resistant strains (CAKR7, MIC â‰¥ 64â€‰Âµg/mL and CAGL2 MIC â‰¥ 64â€‰Âµg/mL) were treated with 4â€‰Âµg/mL fluconazole and no effect on sterol profile was observed. However, when CAKR7 and CAGL2 strains were treated with <b>8â€‰g</b> at the same dose, a significant diminution of ergosterol content was observed (25% to 47%) as well as an accumulation of lanosterol or obtusifoliol. As for CAAL93, a production of 14Î±-methyl-sterols was observed: eburicol, 14Î±-methylfecosterol and 14Î±-methylepisterol. Toxic 14Î±-methyl-diol was even detected for CAGL2 (23%). Modifications in sterol profiles after treatment with <b>8â€‰g</b> confirmed the blockage of 14Î±-demethylase (ERG11) by this compound.</p> </div> <div class="discussion" title="discussion"> <div class="title" tagx="title" title="title">
Discussion</div> <p>Development of new antifungal drugs implies a high level of activity against targeted fungi and acceptable toxicity against host cells. In this aim, we have developed a new family of azole derivatives, indolyl-triazoles<a href="#CIT0025"><sup>25</sup></a>, that could inhibit yeast growth at low concentrations (MIC<sub>90</sub>s &amp;lt; 0.50â€‰Âµg/mL). The compound <b>8â€‰g</b> has a broad-spectrum activity against most clinical relevant <i>Candida</i> species. Against all <i>Candida</i> spp., MIC range of <b>8â€‰g</b> (&amp;lt; 0.016 â€" 4â€‰Âµg/mL) was narrower than for fluconazole or voriconazole with MIC ranges of &amp;lt; 0.125 â€" &amp;gt; 64â€‰Âµg/mL and &amp;lt; 0.016 â€" &amp;gt; 8â€‰Âµg/mL, respectively. Against fluconazole low-susceptible spp. (<i>C. glabrata</i> and <i>C. krusei</i>), <b>8â€‰g</b> was more active than fluconazole and voriconazole. Because of their increasing frequency in bloodstream infection and their ability to resist to antifungal drugs, these species are now the real target of new drugs<a href="#CIT0006"><sup>6</sup></a><sup>,</sup><a href="#CIT0028"><sup>28</sup></a>. <b>8â€‰g</b> inhibited their growth at very low concentrations (MIC<sub>90</sub>sâ€‰=â€‰0.25â€‰Âµg/mL) whereas fluconazole and voriconazole have higher MIC<sub>90</sub>s, 64 and 1â€‰Âµg/mL, respectively. Moreover <i>C. albicans</i>, being the most frequently isolated species during invasive candidiasis, is highly sensitive to <b>8â€‰g</b> (MIC<sub>90</sub> &amp;lt; 0.5â€‰Âµg/mL). Second-generation triazole antifungals (voriconazole, posaconazole, isavuconazole) have a broad anti-infectious spectrum. When tested against <i>Aspergillus fumigatus</i>, <b>8â€‰g</b> showed a moderate activity, since the concentration that inhibited 80% of the growth was 23â€‰Âµg/mL. Because triazole derivatives (itraconazole, fluconazole and posaconazole) could inhibit ergosterol-like synthesis in Trypanosomatids<a href="#CIT0029"><sup>29</sup></a>, <b>8â€‰g</b> was tested against <i>Leishmania</i>. Results (data not shown) showed that <b>8â€‰g</b> was effective <i>inÂ vitro</i> (IC<sub>50</sub> = 8â€‰Â±â€‰2â€‰Âµg/mL) against <i>Leishmania mexicana</i> promastigote stage. Further investigations must be done to evaluate activity against the most relevant amastigote stage encountered in human host.</p> <p><i>In vivo</i>, compound <b>8â€‰g</b> confirmed its antifungal activity against <i>C. albicans</i>. In a systemic candidiasis model, it was as effective as fluconazole to allow mice survival. In addition, the modification of the initial administration protocol (the same dose three-times a day instead of twice a day) gave a complete protection. This second protocol also highlighted the importance to spread out the daily dose of <b>8â€‰g</b>, thus providing 24â€‰h of protection against a systemic candidiasis.</p> <p>Several events are involved in the membrane biosynthesis, especially the production of lipids as sterols and phospholipids. We demonstrated that <b>8â€‰g</b> inhibits <i>Candida</i> ergosterol synthesis as observed with other azole drugs. This inhibition led to membrane integrity perturbations through ergosterol depletion, precursor accumulation (lanosterol) and production of alternative 14Î±-methyl sterols (14Î±-methyl-fecosterol, 14Î±-methyl-episterol and 14Î±-methyl-3,6-diol). Identification of 14Î±-methylated sterols evidenced a blockage of CYP51 as a way of action of <b>8â€‰g</b>. Interestingly, the effects of <b>8â€‰g</b> on sterol metabolism are observed in CAAL93 (fluconazole susceptible strain) at 4â€‰ng/mL whereas the same results are observed after fluconazole treatment at a 1000-fold higher concentration (4â€‰Âµg/mL). Moreover, the same effects are seen when fluconazole-resistant strains (CAKR7 and CAGL2) were treated by <b>8â€‰g</b> at 4â€‰Âµg/mL whereas nothing happened after treatment with the same dose of fluconazole. These results show the potency of this new indole-triazole derivative compound.</p> <p>Phospholipids are vital structural and functional entities of biomembranes. Phosphatidylcholine, the major phospholipid, is in part metabolised by phospholipases A (PLAs). These enzymes are known to be essentials for the turnover of the membrane phospholipids. Pugh <i>et</i>Â <i>al</i> showed that PLAs were present at the site of bud formation suggesting that they are involved in growth and change in shape of the cell wall<a href="#CIT0021"><sup>21</sup></a>. With a different approach, previously used by Le Pape <i>et</i>Â <i>al</i>, we described a sn-2 hydrolytic phospholipase (PLA<sub>2</sub>) activity in <i>Candida albicans</i><a href="#CIT0030"><sup>30</sup></a>. After 1-h contact time, this activity was inhibited by <b>8â€‰g</b> suggesting an interaction with somatic PLA2-like lipase. Whereas BpB decreased 12% of the glycerophospholipid hydrolysis, <b>8â€‰g</b> did not inhibit the secreted phospholipase activity (data not shown). However, no gene coding for PLA2 was identified in yeast but lipases with patatin-like domains which have a cPLA2-like activity, have already been described in <i>Saccharomyces cerevisiae</i> and in <i>C. albicans</i><a href="#CIT0022"><sup>22</sup></a><sup>,</sup><a href="#CIT0031"><sup>31</sup></a>. Patatin-like phospholipases role is well established for membrane biogenis and sporulation, but their implication in virulence or pathogenesis had still to be determined. Such enzymes could be future targets for new antifungals. Thus, high <b>8â€‰g</b> concentrations (10â€‰ÂµM) could inhibit cell phospholipid organisation and could complete the main mechanism of action, e.g. inhibition of sterol biosynthesis.</p> <p>Because of moderate toxicity on MRC5 cells but very low MIC against <i>Candida,</i> our compound exhibited a good safety (toxicity index = 280) as observed for reference drugs (fluconazole and voriconazole).</p> <p>In conclusion, <b>8â€‰g</b> showed high <i>inÂ vitro</i> activity against <i>Candida</i>, including low fluconazole-susceptible species (<i>C. krusei</i> and <i>C. glabrata</i>) which remain one of the main challenges in candidiasis therapy. Its mechanism of action involved a strong blockage of CYP51 and in a minor importance inhibition of PLA<sub>2</sub>-like activity. This promising compound has low toxicity on MRC5 cells and a significant <i>in</i>Â <i>vivo</i> activity. Further investigations must be done to evaluate antifungal activity of <b>8â€‰g</b> and its enantiomers in <i>inÂ vivo</i> models of candidiasis and against other fungi.</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>A doctoral scholarship from the Research Association AGISMED to Mr Y-M. Na and Mr N. Lebouvier are gratefully acknowledged. We are also grateful to Mr. and Mrs. Le Floch (Yanikem s.a.r.l.) for their continued support.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brown</span><span class="given-names" tagx="given-names" title="given-names">GD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Denning</span><span class="given-names" tagx="given-names" title="given-names">DW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Levitz</span><span class="given-names" tagx="given-names" title="given-names">SM.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Tackling human fungal infections</span>. <span class="source" tagx="source" title="source">Science</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">336</span>:<span class="fpage" tagx="fpage" title="fpage">647</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22582229">22582229</a></span></span></li> <li tag="ref"><a name="CIT0002" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pappas</span><span class="given-names" tagx="given-names" title="given-names">PG</span></span>, <span class="collab'">collab: NIAID Mycoses Study Group</span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rex</span><span class="given-names" tagx="given-names" title="given-names">JH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients</span>. <span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="year" tagx="year" title="year">2003</span>;<span class="volume" tagx="volume" title="volume">37</span>:<span class="fpage" tagx="fpage" title="fpage">634</span>â€"<span class="lpage" tagx="lpage" title="lpage">43</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12942393">12942393</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">BJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wannemuehler</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marston</span><span class="given-names" tagx="given-names" title="given-names">BJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS</span>. <span class="source" tagx="source" title="source">Aids</span><span class="year" tagx="year" title="year">2009</span>; <span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">525</span>â€"<span class="lpage" tagx="lpage" title="lpage">30</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19182676">19182676</a></span></span></li> <li tag="ref"><a name="CIT0004" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pappas</span><span class="given-names" tagx="given-names" title="given-names">PG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kauffman</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andes</span><span class="given-names" tagx="given-names" title="given-names">DR</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America</span>. <span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">62</span>:<span class="fpage" tagx="fpage" title="fpage">e1</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26679628">26679628</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pfaller</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boyken</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hollis</span><span class="given-names" tagx="given-names" title="given-names">RJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title"><i>InÂ vitro</i> susceptibilities of <i>Candida spp</i>. to caspofungin: four years of global surveillance</span>. <span class="source" tagx="source" title="source">J Clin Microbiol</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">44</span>:<span class="fpage" tagx="fpage" title="fpage">760</span>â€"<span class="lpage" tagx="lpage" title="lpage">3</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16517851">16517851</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alexander</span><span class="given-names" tagx="given-names" title="given-names">BD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Johnson</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pfeiffer</span><span class="given-names" tagx="given-names" title="given-names">CD</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Increasing echinocandin resistance in <i>Candida glabrata</i>: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations</span>. <span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">56</span>:<span class="fpage" tagx="fpage" title="fpage">1724</span>â€"<span class="lpage" tagx="lpage" title="lpage">32</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23487382">23487382</a></span></span></li> <li tag="ref"><a name="CIT0007" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Oliveira Santos</span><span class="given-names" tagx="given-names" title="given-names">GC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vasconcelos</span><span class="given-names" tagx="given-names" title="given-names">CC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lopes</span><span class="given-names" tagx="given-names" title="given-names">AJO</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title"><i>Candida</i> infections and therapeutic strategies: mechanisms of action for traditional and alternative agents</span>. <span class="source" tagx="source" title="source">Front Microbiol</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">1351</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30018595">30018595</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carrillo-MuÃ±oz</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giusiano</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ezkurra</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">QuindÃ³s</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antifungal agents: mode of action in yeast cells</span>. <span class="source" tagx="source" title="source">Rev Esp Quimioter</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">130</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16964330">16964330</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Whaley</span><span class="given-names" tagx="given-names" title="given-names">SG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Berkow</span><span class="given-names" tagx="given-names" title="given-names">EL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rybak</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Azole antifungal resistance in <i>Candida albicans</i> and emerging non-<i>albicans Candida</i> species</span>. <span class="source" tagx="source" title="source">Front Microbiol</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">2173</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28127295">28127295</a></span></span></li> <li tag="ref"><a name="CIT0010" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kale</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Johnson</span><span class="given-names" tagx="given-names" title="given-names">LB.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Second-generation azole antifungal agents</span>. <span class="source" tagx="source" title="source">Drugs Today (Barc</span>) <span class="year" tagx="year" title="year">2005</span>;<span class="volume" tagx="volume" title="volume">41</span>:<span class="fpage" tagx="fpage" title="fpage">91</span>â€"<span class="lpage" tagx="lpage" title="lpage">105</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15821782">15821782</a></span></span></li> <li tag="ref"><a name="CIT0011" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pouliot</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeanmart</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">59</span>:<span class="fpage" tagx="fpage" title="fpage">497</span>â€"<span class="lpage" tagx="lpage" title="lpage">503</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26313340">26313340</a></span></span></li> <li tag="ref"><a name="CIT0012" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Na</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le</span><span class="given-names" tagx="given-names" title="given-names">BM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pagniez</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2003</span>;<span class="volume" tagx="volume" title="volume">38</span>:<span class="fpage" tagx="fpage" title="fpage">75</span>â€"<span class="lpage" tagx="lpage" title="lpage">87</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12593918">12593918</a></span></span></li> <li tag="ref"><a name="CIT0013" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pagniez</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Borgne</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marchand</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro activity of a new antifungal azolyl-substituted indole against <i>Aspergillus fumigatus</i></span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2002</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">425</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12683679">12683679</a></span></span></li> <li tag="ref"><a name="CIT0014" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marchand</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Borgne</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Na</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antileishmanial activity of 3-(alpha-azolylbenzyl)indoles</span>. <span class="source" tagx="source" title="source">J. Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2002</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">353</span>â€"<span class="lpage" tagx="lpage" title="lpage">8</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12683669">12683669</a></span></span></li> <li tag="ref"><a name="CIT0015" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Na</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lebouvier</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Borgne</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">451</span>â€"<span class="lpage" tagx="lpage" title="lpage">7</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15662948">15662948</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Price</span><span class="given-names" tagx="given-names" title="given-names">MF</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cawson</span><span class="given-names" tagx="given-names" title="given-names">RA.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Phospholipase activity in <i>Candida albicans</i></span>. <span class="source" tagx="source" title="source">Sabouraudia</span><span class="year" tagx="year" title="year">1977</span>;<span class="volume" tagx="volume" title="volume">15</span>:<span class="fpage" tagx="fpage" title="fpage">179</span>â€"<span class="lpage" tagx="lpage" title="lpage">85</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/333624">333624</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mago</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khuller</span><span class="given-names" tagx="given-names" title="given-names">GK.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Subcellular localization of enzymes of phospholipid metabolism in <i>Candida albicans</i></span>. <span class="source" tagx="source" title="source">J Med Vet Mycol</span><span class="year" tagx="year" title="year">1990</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">355</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2283583">2283583</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rossoni</span><span class="given-names" tagx="given-names" title="given-names">RD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barbosa</span><span class="given-names" tagx="given-names" title="given-names">JO</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vilela</span><span class="given-names" tagx="given-names" title="given-names">SF</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Correlation of phospholipase and proteinase production of <i>Candida</i> with <i>inÂ vivo</i> pathogenicity in <i>Galleria mellonella</i></span>. <span class="source" tagx="source" title="source">Braz J Oral Sci</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">199</span>â€"<span class="lpage" tagx="lpage" title="lpage">204</span>.</span></li> <li tag="ref"><a name="CIT0019" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fule</span><span class="given-names" tagx="given-names" title="given-names">SR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Das</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fule</span><span class="given-names" tagx="given-names" title="given-names">RP.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Detection of phospholipase activity of <i>Candida albicans</i> and non albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area</span>. <span class="source" tagx="source" title="source">Indian J Med Microbiol</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">33</span>:<span class="fpage" tagx="fpage" title="fpage">92</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25560009">25560009</a></span></span></li> <li tag="ref"><a name="CIT0020" /><span class="label" tagx="label" title="label">20</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghannoum</span><span class="given-names" tagx="given-names" title="given-names">MA.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Potential role of phospholipases in virulence and fungal pathogenesis</span>. <span class="source" tagx="source" title="source">Clin Microbiol Rev</span><span class="year" tagx="year" title="year">2000</span>;<span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">122</span>â€"<span class="lpage" tagx="lpage" title="lpage">43</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10627494">10627494</a></span></span></li> <li tag="ref"><a name="CIT0021" /><span class="label" tagx="label" title="label">21</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pugh</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cawson</span><span class="given-names" tagx="given-names" title="given-names">RA.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The cytochemical localization of phospholipase A and lysophospholipase in <i>Candida albicans</i></span>. <span class="source" tagx="source" title="source">Sabouraudia</span><span class="year" tagx="year" title="year">1975</span>;<span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">110</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1091995">1091995</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¶hler</span><span class="given-names" tagx="given-names" title="given-names">GA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brenot</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haas-Stapleton</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Phospholipase A2 and phospholipase B activities in fungi</span>. <span class="source" tagx="source" title="source">Biochim Biophys Acta</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">1761</span>:<span class="fpage" tagx="fpage" title="fpage">1391</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17081801">17081801</a></span></span></li> <li tag="ref"><a name="CIT0023" /><span class="label" tagx="label" title="label">23</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schevitz</span><span class="given-names" tagx="given-names" title="given-names">RW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bach</span><span class="given-names" tagx="given-names" title="given-names">NJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carlson</span><span class="given-names" tagx="given-names" title="given-names">DG</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Structure-based design of the first potent and elective inhibitor of human non-pancreatic secretory phospholipase A2</span>. <span class="source" tagx="source" title="source">Nat Struct Biol</span><span class="year" tagx="year" title="year">1995</span>;<span class="volume" tagx="volume" title="volume">2</span>:<span class="fpage" tagx="fpage" title="fpage">458</span>â€"<span class="lpage" tagx="lpage" title="lpage">65</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7664108">7664108</a></span></span></li> <li tag="ref"><a name="CIT0024" /><span class="label" tagx="label" title="label">24</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Binder</span><span class="given-names" tagx="given-names" title="given-names">U</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lass-FlÃ¶rl</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiology of invasive fungal infections in the Mediterranean</span>. <span class="source" tagx="source" title="source">Mediterr J Hematol Infect Dis</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">e20110016</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21625305">21625305</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="label" tagx="label" title="label">25</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">(a) <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Borgne</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Na</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pagniez</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition. US 0067998. <span class="year" tagx="year" title="year">2004</span>;</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">(b) <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lebouvier</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giraud</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Corbin</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Efficient microwave-assisted synthesis of 1-(1<i>H</i>-indol-1-yl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents</span>. <span class="source" tagx="source" title="source">Tetrahedron Lett</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">47</span>:<span class="fpage" tagx="fpage" title="fpage">6479</span>â€"<span class="lpage" tagx="lpage" title="lpage">83</span>;</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">(c) <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lebouvier</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pagniez</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duflos</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">3686</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17482460">17482460</a></span></span></li> <li tag="ref"><a name="CIT0026" /><span class="label" tagx="label" title="label">26</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="source" tagx="source" title="source">Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards Reference method for broth dilution susceptibility testing of yeasts: approved standard, 2nd ed. Document M27-A2</span>. Clinical and Laboratory Standards Institute. <span class="year" tagx="year" title="year">2002</span>; Wayne P.</span></li> <li tag="ref"><a name="CIT0027" /><span class="label" tagx="label" title="label">27</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alvarez-Rueda</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fleury</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morio</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Amino acid substitutions at the major insertion loop of <i>Candida albicans</i> sterol 14alpha-demethylase are involved in fluconazole resistance</span>. <span class="source" tagx="source" title="source">PLoS One</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">e21239</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21698128">21698128</a></span></span></li> <li tag="ref"><a name="CIT0028" /><span class="label" tagx="label" title="label">28</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scorzoni</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Paula</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Silva</span><span class="given-names" tagx="given-names" title="given-names">AC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marcos</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Antifungal therapy: new advances in the understanding and treatment of mycosis</span>. <span class="source" tagx="source" title="source">Front Microbiol</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">36</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28167935">28167935</a></span></span></li> <li tag="ref"><a name="CIT0029" /><span class="label" tagx="label" title="label">29</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roberts</span><span class="given-names" tagx="given-names" title="given-names">CW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McLeod</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rice</span><span class="given-names" tagx="given-names" title="given-names">DW</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa</span>. <span class="source" tagx="source" title="source">Mol Biochem Parasitol</span><span class="year" tagx="year" title="year">2003</span>;<span class="volume" tagx="volume" title="volume">126</span>:<span class="fpage" tagx="fpage" title="fpage">129</span>â€"<span class="lpage" tagx="lpage" title="lpage">42</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12615312">12615312</a></span></span></li> <li tag="ref"><a name="CIT0030" /><span class="label" tagx="label" title="label">30</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Pape</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zidane</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abdala</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">More</span><span class="given-names" tagx="given-names" title="given-names">MT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A glycoprotein isolated from sponge, <i>Pachymatisma johnstonii</i>, has anti-leishmanial activity</span>. <span class="source" tagx="source" title="source">Cell Biol Intern</span><span class="year" tagx="year" title="year">2000</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">51</span>â€"<span class="lpage" tagx="lpage" title="lpage">6</span>.</span></li> <li tag="ref"><a name="CIT0031" /><span class="label" tagx="label" title="label">31</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Senda</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yoshioka</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doke</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kawakita</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A cytosolic phospholipase A2 from potato tissues appears to be patatin</span>. <span class="source" tagx="source" title="source">Plant Cell Physiol</span><span class="year" tagx="year" title="year">1996</span>;<span class="volume" tagx="volume" title="volume">37</span>:<span class="fpage" tagx="fpage" title="fpage">347</span>â€"<span class="lpage" tagx="lpage" title="lpage">53</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8673343">8673343</a></span></span></li> </ul> </div> </div>  </body></html>